ArticleMicrobiology spectrum2023

Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis.

Wang Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.